Results 111 to 120 of about 4,958,442 (285)

Single-electron tunneling depressing synapse for cellular neural networks

open access: yes, 2008
In this paper, a cellular neural network with depressing synapses for contrast-invariant pattern classification and synchrony detection is presented, starting from the impulse model of the single-electron tunneling junction.
Li, N, Chinese Acad Sci, Inst Semicond, Lab Artificial Neural Networks, POB 912, Beijing 100083, Peoples R China. 电子邮箱地址: ningli@red.semi.ac.cn   +2 more
core  

Medical analysis and diagnosis by neural networks [PDF]

open access: yes, 2010
In its first part, this contribution reviews shortly the application of neural network methods to medical problems and characterizes its advantages and problems in the context of the medical background.
Brause, Rüdiger W.
core  

Integrating convolutional neural networks into a sparse distributed representation model based on mammalian cortical learning

open access: yes, 2016
Biological brains exhibit a remarkable capacity to recognise real-world patterns effectively. Despite major advances in neuroscience over the last few decades, an understanding of the brain's underlying mechanisms for pattern recognition remains ...
Daniel E. Padilla   +3 more
core   +1 more source

Juvenile Huntington Disease With Cerebellar‐Predominant Atrophy Identified by Genome Sequencing

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Juvenile Huntington disease accounts for a small fraction of Huntington disease cases and is driven by the largest trinucleotide repeat expansions. We describe a 6‐year‐old boy with progressive global regression, generalized dystonia, and epilepsy, in whom serial imaging showed striking cerebellar‐predominant atrophy with an initially normal ...
Enrique Gonzalez Saez‐Diez   +5 more
wiley   +1 more source

Stage‐Specific Patterns of Imaging and Non‐Motor Biomarkers in Spinocerebellar Ataxia Type 3

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Advancements in disease‐modifying therapies for spinocerebellar ataxia Type 3 (SCA3) underscore the need for robust biomarkers to monitor disease progression and evaluate treatment efficacy. Although motor phenotypes have been well characterized, less is known about non‐motor and imaging‐based features across different disease stages.
Chun Li   +17 more
wiley   +1 more source

Simulation of land use changes using cellular automata and artificial neural network [PDF]

open access: yes
This paper presents a method integrating artificial neural network (ANN) in cellular automata (CA) to simulate land use changes in Luxembourg and the areas adjacent to its borders. The ANN is used as a base of CA model transition rule.
BASSE Reine Maria   +4 more
core  

Clinical Variability and Genotype Driven Outcomes in an International Cohort of 14 Pediatric FIG4 Patients

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Biallelic FIG4 variants classically cause distinct conditions characterized by peripheral neuropathy (Charcot‐Marie‐Tooth disease type 4J) or skeletal dysplasia (Yunis‐Varón syndrome). However, central nervous system involvement is increasingly recognized. The prevalence and specific characteristics of movement disorders within FIG4‐
Andrea Gangfuß   +22 more
wiley   +1 more source

Almost sure exponential stability of delayed cellular neural networks

open access: yesElectronic Journal of Differential Equations, 2007
The stability of stochastic delayed Cellular Neural Networks (DCNN) is investigated in this paper. Using suitable Lyapunov functional and the semimartingale convergence theorem, we obtain some sufficient conditions for checking the almost sure ...
Chuangxia Huang, Yigang He, Lihong Huang
doaj  

Myostatin/Smad3 in Spinal Muscular Atrophy: Biomarkers of Disease Severity and Treatment Response

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Given the role of Myostatin (MSTN) in muscle homeostasis and its modulation by current spinal muscular atrophy (SMA) therapies, we investigated serum MSTN and, for the first time, its downstream effector Smad3 as candidate non‐invasive biomarkers in SMA patients undergoing disease‐modifying therapies (DMTs).
Giorgia Riolo   +11 more
wiley   +1 more source

Artificial Intelligence in Systemic Sclerosis: Clinical Applications, Challenges, and Future Directions

open access: yesArthritis Care &Research, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy